Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024;20(5):3708-3821.
Rajan KB, Weuve J, Barnes LL, et al. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement. 2021;17(12):1966-1975.
Stessman J, Jacobs JM. Dementia and mild cognitive impairment: prevalence, conversion rates, and longevity between ages 70 and 95. Innov Aging. 2023;7(suppl 1):743.
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Commission. Lancet. 2024;404(10452):572-628.
- US Department of Health and Human Services. Medicare wellness visits. November 2024. Accessed January 5, 2025. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/preventive-services/medicare-wellness-visits.html#AWV
Owens DK, Davidson KW, Krist AH, et al.; US Preventive Services Task Force. Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(8):757-763.
- Patnode CD, Perdue LA, Rossom RC, et al. Screening for Cognitive Impairment in Older Adults:An Evidence Update for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US); 2020. Accessed January 5, 2025. https://www.ncbi.nlm.nih.gov/books/NBK554654/
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126-135.
Atri A, Dickerson BC, Clevenger C, et al. Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD-ADRD): executive summary of recommendations for primary care. Alzheimers Dement. 2025;21(6):e14333.
Falk N, Cole A, Meredith TJ. Evaluation of suspected dementia. Am Fam Physician. 2018;97(6):398-405.
- McCabe D. Katz index of independence in activities of daily living (ADL). Accessed January 5, 2025. https://hign.org/consultgeri/try-this-series/katz-index-independence-activities-daily-living-adl
- Coyne R. The Lawton Instrumental Activities of Daily Living (IADL) scale. Accessed January 5, 2025. https://hign.org/consultgeri/try-this-series/lawton-instrumental-activities-daily-living-iadl-scale
- Alzheimer’s Association. 10 early signs and symptoms of Alzheimer’s and dementia. Accessed January 8, 2025. https://www.alz.org/alzheimers-dementia/10_signs
Simel DL, Holsinger T, Deveau J, et al. Dementia. In: Simel DL, Rennie D, Keitz SA, eds. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. McGraw-Hill Medical; 2009.
Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med. 2014;30(3):421-442.
Knopman DS, Petersen RC. Mild cognitive impairment and mild dementia: a clinical perspective. Mayo Clin Proc. 2014;89(10):1452-1459.
Abayomi SN, Sritharan P, Yan E, et al. The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment— a systematic review and meta-analysis. PLoS One. 2024;19(3):e0298686.
Modrego PJ, Gazulla J. The predictive value of the memory impairment screen in patients with subjective memory complaints: a prospective study. Prim Care Companion CNS Disord. 2013;15(1) ): PCC.12m01435.
Kuslansky G, Buschke H, Katz M, et al. Screening for Alzheimer’s disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc. 2002;50(6):1086-1091.
Tsoi KKF, Chan JYC, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(9):1450-1458.
Stewart C, Stewart J, Stubbs S, et al. Mini-Cog IQCODE, MoCA, and MMSE for the prediction of dementia in primary care. Am Fam Physician. 2022;105(6):590-591.
Cummings-Vaughn LA, Chavakula NN, Malmstrom TK, et al. Veterans Affairs Saint Louis University Mental Status examination compared with the Montreal Cognitive Assessment and the Short Test of Mental Status. J Am Geriatr Soc. 2014;62(7):1341-1346.
Davis DH, Creavin ST, Yip JL, et al. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database Syst Rev. 2021(7):CD010775.
Tariq SH, Tumosa N, Chibnall JT, et al. Comparison of the Saint Louis University Mental Status examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry. 2006;14(11):900-910.
Naqvi RM, Haider S, Tomlinson G, et al. Cognitive assessments in multicultural populations using the Rowland Universal Dementia Assessment Scale: a systematic review and meta-analysis. CMAJ. 2015;187(5):e169-e175.
Iype T, Ajitha BK, Antony P, et al. Usefulness of the Rowland Universal Dementia Assessment scale in South India. J Neurol Neurosurg Psychiatry. 2006;77(4):513-514.
Sorbi S, Hort J, Erkinjuntti T, et al.; EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19(9):1159-1179.
Islam N, Hashem R, Gad M, et al. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Dement. 2023;19(7):3235-3243.
Wright AEH, Harrell HE. Physical examination in the evaluation of dementia. Med Clin North Am. 2022;106(3):471-482.
Simmons BB, Hartmann B, Dejoseph D. Evaluation of suspected dementia. Am Fam Physician. 2011;84(8):895-902.
Fazio S, Pace D, Maslow K, et al. Alzheimer’s Association dementia care practice recommendations. Gerontologist. 2018;58(suppl 1):S1-S9.
Wei H, Masurkar AV, Razavian N. On gaps of clinical diagnosis of dementia subtypes: a study of Alzheimer’s disease and Lewy body disease. Front Aging Neurosci. 2023;15:1149036.
Goodman RA, Lochner KA, Thambisetty M, et al. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimers Dement. 2017;13(1):28-37.
- American College of Radiology. ACR Appropriateness Criteria Dementia. 2024. Accessed January 5, 2025. https://acsearch.acr.org/docs/3111292/Narrative
Ebell MH, Barry HC, Baduni K, et al. Clinically important benefits of harms of monoclonal antibodies targeting amyloid for the treatment of Alzheimer disease: a systematic review and meta-analysis. Ann Fam Med. 2024;22(1):50-62.
Yamada M, Komatsu J, Nakamura K, et al. Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord. 2020;13(1):1-10.
Mok VCT, Cai Y, Markus HS. Vascular cognitive impairment and dementia: mechanisms, treatment, and future directions. Int J Stroke. 2024;19(8):838-856.
Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? BMC Med. 2018;16(1):34.
McKeith I, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992;305(6855):673-678.
Lanoiselée HM, Nicolas G, Wallon D, et al.; Collaborators of the CNR-MAJ Project. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14(3):e1002270.
Lee J. Mild cognitive impairment in relation to Alzheimer’s disease: an investigation of principles, classifications, ethics, and problems. Neuroethics. 2023;16(2):16.
Papaliagkas V, Kalinderi K, Vareltzis P, et al. CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer’s disease. Int J Mol Sci. 2023;24(10):8976.
Anderson J, Pierce C. PrecivityAD for diagnosis of Alzheimer disease. Am Fam Physician. 2022;105(1):79-81.
Lau K, Lin KW. Lumipulse G β-amyloid ratio test for the diagnosis of Alzheimer disease. Am Fam Physician. 2023;107(5):550-551.
Palmqvist S, Tideman P, Mattsson-Carlgren N, et al. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA. 2024;332(15):1245-1257.
Schroeder RW, Martin PK, Walling A. Neuropsychological evaluations in adults. Am Fam Physician. 2019;99(2):101-108.
Galvin JE, Sadowsky CH. NINCDS-ADRDA. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012;25(3):367-382.
Adelman AM, Daly MP. Initial evaluation of the patient with suspected dementia. Am Fam Physician. 2005;71(9):1745-1750.
Santacruz KS, Swagerty D. Early diagnosis of dementia. Am Fam Physician. 2001;63(4):703-714.